Lipoprotein(a) and Major Adverse Cardiovascular Events in Patients With or Without Baseline Atherosclerotic Cardiovascular Disease.

MLA

Berman, Adam N., et al. “Lipoprotein(a) and Major Adverse Cardiovascular Events in Patients With or Without Baseline Atherosclerotic Cardiovascular Disease.” Journal of the American College of Cardiology, vol. 83, no. 9, Mar. 2024, pp. 873–86. EBSCOhost, https://doi.org/10.1016/j.jacc.2023.12.031.

APA

Berman, A. N., Biery, D. W., Besser, S. A., Singh, A., Shiyovich, A., Weber, B. N., Huck, D. M., Divakaran, S., Hainer, J., Kaur, G., Blaha, M. J., Cannon, C. P., Plutzky, J., Januzzi, J. L., Booth, J. N., 3rd, López, J. A. G., Kent, S. T., Nasir, K., Di Carli, M. F., … Blankstein, R. (2024). Lipoprotein(a) and Major Adverse Cardiovascular Events in Patients With or Without Baseline Atherosclerotic Cardiovascular Disease. Journal of the American College of Cardiology, 83(9), 873–886. https://doi.org/10.1016/j.jacc.2023.12.031

Chicago

Berman, Adam N, David W Biery, Stephanie A Besser, Avinainder Singh, Arthur Shiyovich, Brittany N Weber, Daniel M Huck, et al. 2024. “Lipoprotein(a) and Major Adverse Cardiovascular Events in Patients With or Without Baseline Atherosclerotic Cardiovascular Disease.” Journal of the American College of Cardiology 83 (9): 873–86. doi:10.1016/j.jacc.2023.12.031.